666
Views
0
CrossRef citations to date
0
Altmetric
Review Articles

The effects of cereal β-glucans on cardiovascular risk factors and the role of the gut microbiome

, &

References

  • AbuMweis, S. S., S. Jew, and N. P. Ames. 2020. β-glucan from barley and its lipid-lowering capacity: A meta-analysis of randomized, controlled trials. European Journal of Clinical Nutrition 64 (12):1472–80. doi: 10.1038/ejcn.2010.178.
  • Aleixandre, A., and M. Miguel. 2016. Dietary fibre and blood pressure control. Food & Function 7 (4):1864–71. doi: 10.1039/c5fo00950b.
  • Alharbi, H. F., R. Algonaiman, and H. Barakat. 2022. Ameliorative and antioxidative potential of Lactobacillus plantarum-fermented oat (Avena sativa) and fermented oat supplemented with Sidr honey against streptozotocin-induced type 2 diabetes in rats. Antioxidants 11 (6):1122. doi: 10.3390/antiox11061122.
  • Alvaro, A., R. Solà, R. Rosales, J. Ribalta, A. Anguera, L. Masana, and J. C. Vallvé. 2008. Gene expression analysis of a human enterocyte cell line reveals downregulation of cholesterol biosynthesis in response to short-chain fatty acids. IUBMB life 60 (11):757–64. doi: 10.1002/iub.110.
  • Anderson, T. J., I. T. Meredith, A. C. Yeung, B. Frei, A. P. Selwyn, and P. Ganz. 1995. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. The New England Journal of Medicine 332 (8):488–93. doi: 10.1056/NEJM199502233320802.
  • Armet, A. M., E. C. Deehan, A. F. O’Sullivan, J. F. Mota, C. J. Field, C. M. Prado, A. J. Lucey, and J. Walter. 2022. Rethinking healthy eating in light of the gut microbiome. Cell Host & Microbe 30 (6):764–85. doi: 10.1016/j.chom.2022.04.016.
  • Bae, I. Y., S. M. Kim, S. Lee, and H. G. Lee. 2010. Effect of enzymatic hydrolysis on cholesterol lowering activity of oat beta-glucan. New Biotechnology 27 (1):85–8. doi: 10.1016/j.nbt.2009.11.003.
  • Bai, J., J. Zhao, W. Al-Ansi, J. Wang, L. Xue, J. Liu, Y. Wang, M. Fan, H. Qian, Y. Li, et al. 2021. Oat β-glucan alleviates DSS-induced colitis via regulating gut microbiota metabolism in mice. Food & Function 12 (19):8976–93. doi: 10.1039/d1fo01446c.
  • Bai, J., T. Li, W. Zhang, M. Fan, H. Qian, Y. Li, and L. Wang. 2021. Systematic assessment of oat β-glucan catabolism during in vitro digestion and fermentation. Food Chemistry 348:129116. 30 doi: 10.1016/j.foodchem.2021.129116.
  • Barsanti, L., V. Passarelli, V. Evangelista, A. M. Frassanito, and P. Gualtieri. 2011. Chemistry, physico-chemistry and applications linked to biological activities of β-glucans. Natural Product Reports 28 (3):457–66. doi: 10.1039/c0np00018c.
  • Bashir, K., and J. S. Choi. 2017. Clinical and physiological perspectives of β-glucans: The past, present, and future. International Journal of Molecular Sciences 18 (9):1906. doi: 10.3390/ijms18091906.
  • Behall, K. M., D. J. Scholfield, and J. Hallfrisch. 2004. Diets containing barley significantly reduce lipids in mildly hypercholesterolemic men and women. The American Journal of Clinical Nutrition 80 (5):1185–93. doi: 10.1093/ajcn/80.5.1185.
  • Bernalier-Donadille, A. 2012. Fermentative metabolism by the human gut microbiota. Gastroenterologie Clinique et Biologique 34(Suppl 1):S16–S22. doi: 10.1016/S0399-8320(10)70016-6.
  • Borchani, C., F. Fonteyn, G. Jamin, J. Destain, L. Willems, M. Paquot, C. Blecker, P. Thonart, B. Chema, F. Fabienne, et al. 2015. Structural characterization, technological functionality and physiological aspects of fungal β-D-glucans: A review. Critical Reviews in Food Science and Nutrition 56 (10):1746–52. doi: 10.1080/10408398.2013.854733.
  • Bull, M. J., and N. T. Plummer. 2014. Part 1: The human gut microbiome in health and disease. Integrative medicine (Encinitas, Calif) 13(6), 17–22.
  • Canani, R. B., M. D. Costanzo, L. Leone, M. Pedata, R. Meli, and A. Calignano. 2011. Potential beneficial effects of butyrate in intestinal and extraintestinal diseases. World Journal of Gastroenterology 17 (12):1519–28. doi: 10.3748/wjg.v17.i12.1519.
  • Catry, E., B. D. Pachikian, N. Salazar, A. M. Neyrinck, P. D. Cani, and N. M. Delzenne. 2015. Ezetimibe and simvastatin modulate gut microbiota and expression of genes related to cholesterol metabolism. Life Sciences 132:77–84. doi: 10.1016/j.lfs.2015.04.004.
  • Chen, C., X. Huang, H. Wang, F. Geng, and S. Nie. 2002. Effect of β-glucan on metabolic diseases: A review from the gut microbiota perspective. Current Opinion in Food Science. 47:100907. doi: 10.1016/j.cofs.2022.100907.
  • Chiang, J. Y. L., and J. M. Ferrell. 2020. Up to date on cholesterol 7 alpha-hydroxylase (CYP7A1) in bile acid synthesis. Liver Research 4 (2):47–63. doi: 10.1016/j.livres.2020.05.001.
  • Cloetens, L., M. Ulmius, A. Johansson-Persson, B. Akesson, and G. Onning. 2012. Role of dietary beta-glucans in the prevention of the metabolic syndrome. Nutrition Reviews 70 (8):444–58. doi: 10.1111/j.1753-4887.2012.00494.x.
  • Connolly, M. L., X. Tzounis, K. M. Tuohy, and J. A. Lovegrove. 2016. Hypocholesterolemic and prebiotic effects of a whole-grain oat-based granola breakfast cereal in a cardio-metabolic "at risk" population. Frontiers in Microbiology 7:1675. doi: 10.3389/fmicb.2016.01675.
  • Cosola, C., M. De Angelis, M. Rocchetti, E. Montemurno, V. Maranzano, G. Dalfino, C. Manno, A. Zito, M. Gesualdo, M. Ciccone, et al. 2017. Beta-glucans supplementation associates with reduction in P-cresyl sulfate levels and improved endothelial vascular reactivity in healthy individuals. PLoS One 12 (1):0169635. 20
  • Davidson, M. H., L. D. Dugan, J. H. Burns, J. Bova, K. Story, and K. B. Drennan. 1991. The hypocholesterolemic effects of b-glucan in oatmeal and oat bran: A dose-controlled study. JAMA 265 (14):1833–9. doi: 10.1001/jama.1991.03460140061027.
  • De Angelis, M., E. Montemurno, L. Vannini, C. Cosola, N. Cavallo, G. Gozzi, V. Maranzano, R. Di Cagno, M. Gobbetti, L. Gesualdo, et al. 2015. Effect of whole-grain barley on the human fecal microbiota and metabolome. Applied and Environmental Microbiology 81 (22):7945–56. doi: 10.1128/AEM.02507-15.
  • de Groot, A., R. Luyken, and N. A. Pikaar. 1963. Cholesterol lowering effect of rolled oats. Lancet (London, England) 2 (7302):303–4. doi: 10.1016/s0140-6736(63)90210-1.
  • de Morais Junior, A. C., R. M. Schincaglia, R. B. Viana, A. M. Armet, C. M. Prado, J. Walter, and J. F. Mota. 2023. The separate effects of whole oats and isolated beta-glucan on lipid profile: A systematic review and meta-analysis of randomized controlled trials. Clinical Nutrition ESPEN 53:224–37. doi: 10.1016/j.clnesp.2022.12.019.
  • Drzikova, B., G. Dongowski, and E. Gebhardt. 2005. Dietary fibre-rich oat-based products affect serum lipids, microbiota, formation of short-chain fatty acids and steroids in rats. The British Journal of Nutrition 94 (6):1012–25. doi: 10.1079/bjn20051577.
  • Du, B., M. Meenu, H. Liu, and B. Xu. 2019. A concise review on the molecular structure and function relationship of β-glucan. International Journal of Molecular Sciences 20 (16):4032. doi: 10.3390/ijms20164032.
  • European Food Safety Authority 2010. Outcome of the public consultation on the draft opinion of the scientific panel on dietetic products, nutrition and allergies (NDA) on dietary reference values for carbohydrates and dietary fibre. EFSA Journal 8 (5):1508.
  • Evans, C., D. Greenwood, D. Threapleton, C. Cleghorn, C. Nykjaer, C. Woodhead, C. Gale, and V. Burley. 2015. Effects of dietary fibre type on blood pressure. Journal of Hypertension 33 (5):897–911. doi: 10.1097/HJH.0000000000000515.
  • Evans, C. 2020. Dietary fibre and cardiovascular health: A review of current evidence and policy. The Proceedings of the Nutrition Society 79 (1):61–7. doi: 10.1017/S0029665119000673.
  • Everard, A., C. Belzer, L. Geurts, J. P. Ouwerkerk, C. Druart, L. B. Bindels, Y. Guiot, M. Derrien, G. G. Muccioli, N. M. Delzenne, et al. 2013. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proceedings of the National Academy of Sciences of the United States of America 110 (22):9066–71. doi: 10.1073/pnas.1219451110.
  • Fernandez-Julia, P. J., J. Munoz-Munoz, and D. van Sinderen. 2021. A comprehensive review on the impact of β-glucan metabolism by Bacteroides and Bifidobacterium species as members of the gut microbiota. International Journal of Biological Macromolecules 181:877–89. doi: 10.1016/j.ijbiomac.2021.04.069.
  • Ferrannini, E., G. Buzzigoli, R. Bonadonna, M. A. Giorico, M. Oleggini, L. Graziadei, R. Pedrinelli, L. Brandi, and S. Bevilacqua. 1987. Insulin resistance in essential hypertension. The New England Journal of Medicine 317 (6):350–7. doi: 10.1056/NEJM198708063170605.
  • Ferri, C., C. Bellini, G. Desideri, M. Valenti, G. De Mattia, A. Santucci, N. K. Hollenberg, and G. H. Williams. 1999. Relationship between insulin resistance and nonmodulating hypertension: Linkage of metabolic abnormalities and cardiovascular risk. Diabetes 48 (8):1623–30. doi: 10.2337/diabetes.48.8.1623.
  • Food and Drug Administration 1996. Food labelling: Health claims: Oats and coronary heart disease. Federal Register. 61:296–313.
  • Fu, L., G. Zhang, S. Qian, Q. Zhang, and M. Tan. 2022. Associations between dietary fiber intake and cardiovascular risk factors: An umbrella review of meta-analyses of randomized controlled trials. Frontiers in Nutrition 9:972399. doi: 10.3389/fnut.2022.972399.
  • Goff, D. C., Jr., H. C. Gerstein, H. N. Ginsberg, W. C. Cushman, K. L. Margolis, R. P. Byington, J. B. Buse, S. Genuth, J. L. Probstfield, and D. G. Simons-Morton. 2007. 2007. Prevention of cardiovascular disease in persons with type 2 diabetes mellitus: Current knowledge and rationale for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. The American Journal of Cardiology 99 (12A):4i–20i. doi: 10.1016/j.amjcard.2007.03.002.
  • Golisch, B., Z. Lei, K. Tamura, and H. Brumer. 2021. Configured for the human gut microbiota: molecular mechanisms of dietary β-glucan utilization. ACS Chemical Biology 16 (11):2087–102. doi: 10.1021/acschembio.1c00563.
  • Hara, H., S. Haga, Y. Aoyama, and S. Kiriyama. 1999. Short-chain fatty acids suppress cholesterol synthesis in rat liver and intestine. The Journal of Nutrition 129 (5):942–8. doi: 10.1093/jn/129.5.942.
  • Hartley, L., M. D. May, E. Loveman, J. L. Colquitt, and K. Rees. 2016. Dietary fibre for the primary prevention of cardiovascular disease. The Cochrane Database of Systematic Reviews 2016 (1):CD011472. Jan 7
  • He, J., R. H. Streiffer, P. Muntner, M. A. Krousel-Wood, and P. K. Whelton. 2004. Effect of dietary fiber intake on blood pressure: A randomized, double-blind, placebo-controlled trial. Journal of Hypertension 22 (1):73–80. doi: 10.1097/00004872-200401000-00015.
  • Ho, H. V., J. L. Sievenpiper, A. Zurbau, M. S. Blanco, E. Jovanovski, F. Au-Yeung, A. L. Jenkins, and V. Vuksan. 2016. A systematic review and meta-analysis of randomized controlled trials of the effect of barley β-glucan on LDL-C, non-HDL-C and apoB for cardiovascular disease risk reduction. European Journal of Clinical Nutrition 70 (11):1239–45. doi: 10.1038/ejcn.2016.89.
  • Hui, S., K. Liu, H. Lang, Y. Liu, X. Wang, X. Zhu, S. Doucette, L. Yi, and M. Mi. 2019. Comparative effects of different whole grains and brans on blood lipid: A network meta-analysis. European Journal of Nutrition 58 (7):2779–87. doi: 10.1007/s00394-018-1827-6.
  • Jayachandran, M., J. Chen, S. Sum Man Chung, and B. Xu. 2018. A critical review on the impacts of β-glucans on gut microbiota and human health. The Journal of Nutritional Biochemistry 61:101–10. doi: 10.1016/j.jnutbio.2018.06.010.
  • Jenkins, D. J., C. W. Kendall, M. Axelsen, L. S. Augustin, and V. Vuk-San. 2000. Viscous and nonviscous fibres, nonabsorbable and low-glycaemic index carbohydrates, blood lipids and coronary heart disease. Current Opinion in Lipidology 11 (1):49–56. doi: 10.1097/00041433-200002000-00008.
  • Jenkins, D. J. A., C. W. C. Kendall, V. Vuksan, E. Vidgen, T. Parker, D. Faulkner, C. C. Mehling, M. Garsetti, G. Testolin, S. C. Cunnane, et al. 2002. Soluble fiber intake at a dose approved by the US Food and Drug Administration for a claim of health benefits: Serum lipid risk factors for cardiovascular disease assessed in a randomized controlled crossover trial. The American Journal of Clinical Nutrition 75 (5):834–9. doi: 10.1093/ajcn/75.5.834.
  • Joyce, S. A., A. Kamil, L. Fleige, and C. G. M. Gahan. 2019. The cholesterol-lowering effect of oats and oat beta glucan: modes of action and potential role of bile acids and the microbiome. Frontiers in Nutrition 6:171. doi: 10.3389/fnut.2019.00171.
  • Kaur, R., M. Sharma, D. Ji, M. Xu, and D. Agyei. 2019. Structural features, modification, and functionalities of beta-glucan. Fibers 8 (1):1. doi: 10.3390/fib8010001.
  • Keenan, J. M., J. J. Pins, C. Frazel, A. Moran, and L. Turnquist. 2002. Oat ingestion reduces systolic and diastolic blood pressure in patients with mild or borderline hypertension: A pilot trial. The Journal of Family Practice 51 (4):369.
  • Keys, A., J. T. Anderson, and F. Grande. 1960. Diet-type (fats constant) and blood lipids in man. The Journal of Nutrition 70 (2):257–66. doi: 10.1093/jn/70.2.257.
  • Khan, K., E. Jovanovski, H. V. T. Ho, A. C. R. Marques, A. Zurbau, S. B. Mejia, J. L. Sievenpiper, and V. Vuksan. 2018. The effect of viscous soluble fibre on blood pressure: A systematic review and meta-analysis of randomized controlled trials. Nutrition, Metabolism, and Cardiovascular Diseases: NMCD 28 (1):3–13. doi: 10.1016/j.numecd.2017.09.007.
  • Khoury, D. E., C. Cuda, B. L. Luhovyy, and G. H. Anderson. 2012. Beta glucan: health benefits in obesity and metabolic syndrome. Journal of Nutrition and Metabolism 2012:851362–28. doi: 10.1155/2012/851362.
  • Kjeldsen, S. E. 2018. Hypertension and cardiovascular risk: General aspects. Pharmacological Research 129:95–9. doi: 10.1016/j.phrs.2017.11.003.
  • Law, M. R., J. K. Morris, and N. J. Wald. 2009. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: Meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ (Clinical Research ed.) 338 (may19 1):b1665–b1665. doi: 10.1136/bmj.b1665.
  • Lee, S. J., D. H. Lee, and H. W. Kim. 2020. Novel antihypertension mechanism of β-glucan by corin and ANP-mediated natriuresis in mice. Mycobiology 48 (5):399–409. doi: 10.1080/12298093.2020.1812150.
  • Lia, A., G. Hallmans, A. S. Sandberg, B. Sundberg, P. Aman, and H. Andersson. 1995. Oat beta-glucan increases bile excretion and a fibre rich barley fracton increases cholesterol excretion in ileostomy subjects. The American Journal of Clinical Nutrition 62 (6):1245–51. doi: 10.1093/ajcn/62.6.1245.
  • Maki, K. C., R. Galant, P. Samuel, J. Tesser, M. S. Witchger, J. D. Ribaya-Mercado, J. B. Blumberg, and J. Geohas. 2007. Effects of consuming foods containing oat beta-glucan on blood pressure, carbohydrate metabolism and biomarkers of oxidative stress in men and women with elevated blood pressure. European Journal of Clinical Nutrition 61 (6):786–95. doi: 10.1038/sj.ejcn.1602562.
  • Mathews, R., A. Kamil, and Y. Chu. 2020. Global review of heart health claims for oat beta-glucan products. Nutrition Reviews 78 (Suppl 1):78–97. doi: 10.1093/nutrit/nuz069.
  • Mejía, S. M. V., A. De Francisco, and B. Bohrer. 2020. A comprehensive review on cereal beta-glucan: Extraction, characterization, causes of degradation, and food application. Critical Reviews in Food Science and Nutrition 60 (21):3693–704. doi: 10.1080/10408398.2019.1706444.
  • Morgado, M., S. Rolo, A. F. Macedo, L. Pereira, and M. Castelo-Branco. 2010. Predictors of uncontrolled hypertension and antihypertensive medication nonadherence. Journal of Cardiovascular Disease Research 1 (4):196–202. doi: 10.4103/0975-3583.74263.
  • Murphy, E. J., E. Rezoagli, I. Major, N. J. Rowan, and J. G. Laffey. 2020. β-glucan metabolic and immunomodulatory properties and potential for clinical application. Journal of Fungi 6 (4):356. 10doi: 10.3390/jof6040356.
  • Musini, V. M., F. Gueyffier, L. Puil, D. M. Salzwedel, and J. M. Wright. 2017. Pharmacotherapy for hypertension in adults aged 18 to 59 years. The Cochrane Database of Systematic Reviews 8 (8):CD008276. doi: 10.1002/14651858.CD008276.pub2.
  • Neter, J. E., B. E. Stam, F. J. Kok, D. E. Grobbee, and J. M. Geleijnse. 2003. Influence of weight reduction on blood pressure: A meta-analysis of randomized controlled trials. Hypertension (Dallas, Tex.: 1979) 42 (5):878–84. doi: 10.1161/01.HYP.0000094221.86888.AE.
  • NICE. 2019. Hypertension in adults: Diagnosis and management; Accessed July 2021; Available at: www.nice.org.uk/guidance/cg127/ chapter/1-Guidance
  • O’Grady, J., E. M. O’Connor, and F. Shanahan. 2019. Review article: Dietary fibre in the era of microbiome science. Alimentary Pharmacology & Therapeutics 49 (5):506–15. doi: 10.1111/apt.15129.
  • Pins, J. J., D. Geleva, J. M. Keenan, C. Frazel, P. J. O’Connor, and L. M. Cherney. 2002. Do whole-grain oat cereals reduce the need for antihypertensive medications and improve blood pressure control? The Journal of Family Practice 51 (4):353–9.
  • Poppitt, S. D. 2007. Soluble fibre oat and barley beta-glucan enriched products: Can we predict cholesterol-lowering effects? The British Journal of Nutrition 97 (6):1049–50. doi: 10.1017/S0007114507690023.
  • Queenan, K. M., M. L. Stewart, K. N. Smith, W. Thomas, R. G. Fulcher, and J. L. Slavin. 2007. Concentrated oat beta-glucan, a fermentable fiber, lowers serum cholesterol in hypercholesterolemic adults in a randomized controlled trial. Nutrition Journal 6 (1):6. doi: 10.1186/1475-2891-6-6.
  • Raj, P., K. Sayfee, L. Yu, A. Sabra, C. Wijekoon, L. Malunga, S. J. Thandapilly, and T. Netticadan. 2023. Oat beta-glucan alone and in combination with hydrochlorothiazide lowers high blood pressure in male but not female spontaneously hypertensive rats. Nutrients 15 (14):3180. doi: 10.3390/nu15143180.
  • Ramkumar, S., A. Raghunath, and S. Raghunath. 2016. Statin therapy: review of safety and potential side effects. Acta Cardiologica Sinica 32 (6):631–9.
  • Rinninella, E., P. Raoul, M. Cintoni, F. Franceschi, G. Miggiano, A. Gasbarrini, and M. C. Mele. 2019. What is the healthy gut microbiota composition? A changing ecosystem across age, environment, diet, and diseases. Microorganisms 7 (1):14. doi: 10.3390/microorganisms7010014.
  • Ripsin, C. M., J. M. Keenan, D. R. Jacobs, P. J. Elmer, R. R. Welch, L. Van Horn, K. Liu, W. H. Turnbull, F. W. Thye, and M. Kestin. 1992. Oat products and lipid lowering: A meta-analysis. JAMA 267 (24):3317–25.
  • Rondanelli, M., A. Opizzi, and F. Monteferrario. 2009. The biological activity of beta-glucans. Minerva Medica 100 (3):237–45.
  • Ryan, P. M., L. E. E. London, T. C. Bjorndahl, R. Mandal, K. Murphy, G. F. Fitzgerald, F. Shanahan, R. P. Ross, D. S. Wishart, N. M. Caplice, et al. 2017. Microbiome and metabolome modifying effects of several cardiovascular disease interventions in apo-E−/− mice. Microbiome. Microbiome 5 (1):30. doi: 10.1186/s40168-017-0246-x.
  • Scientific Advisory Committee on Nutrition 2015. – GOV.UK.2021. Public Health England. Accessed Online June 2021: https://www.gov.uk/government/publications/sacn-carbohydrates-and-health-report.
  • Saltzman, E., S. K. Das, A. H. Lichtenstein, G. E. Dallal, A. Corrales, E. J. Schaefer, A. S. Greenberg, and S. B. Roberts. 2001. An oat-containing hypocaloric diet reduces systolic blood pressure and improves lipid profile beyond effects of weight loss in men and women. The Journal of Nutrition 131 (5):1465–70. doi: 10.1093/jn/131.5.1465.
  • Schmidt, M. 2022. Cereal beta-glucans: An underutilized health endorsing food ingredient. Critical Reviews in Food Science and Nutrition 62 (12):3281–300. doi: 10.1080/10408398.2020.1864619.
  • Sima, P., L. Vannucci, and V. Vetvicka. 2018. β-glucans and cholesterol. International Journal of Molecular Medicine 41 (4):1799–808.
  • Silva, I. M. V., F. Machado, M. J. Moreno, C. Nunes, M. A. Coimbra, and F. Coreta-Gomes. 2021. Polysaccharide structures and their hypocholesterolemic potential. Molecules (Basel, Switzerland) 26 (15):4559. doi: 10.3390/molecules26154559.
  • Soliman, G. A. 2019. Dietary fiber, atherosclerosis, and cardiovascular disease. Nutrients 11 (5):1155. doi: 10.3390/nu11051155.
  • Streppel, M. T., L. R. Arends, P. van ‘t Veer, D. E. Grobbee, and J. M. Geleijnse. 2005. Dietary fiber and blood pressure: A meta-analysis of randomized placebo-controlled trials. Archives of Internal Medicine 165 (2):150–6. doi: 10.1001/archinte.165.2.150.
  • Talati, R., W. L. Baker, M. S. Pabilonia, C. M. White, and C. Coleman. 2009. The effects of barley-derived soluble fibre on serum lipids. Annals of Family Medicine 7 (2):157–63. doi: 10.1370/afm.917.
  • Theuwissen, E., and R. P. Mensink. 2008. Water-soluble dietary fibers and cardiovascular disease. Physiology & Behavior 94 (2):285–92. doi: 10.1016/j.physbeh.2008.01.001.
  • Thies, F., L. F. Masson, P. Boffetta, and P. Kris-Etherton. 2014. Oats and CVD risk markers: A systematic literature review. The British Journal of Nutrition 112 Suppl 2:S19–S30. doi: 10.1017/S0007114514002281.
  • Threapleton, D. E., D. C. Greenwood, C. E. L. Evans, C. L. Cleghorn, C. Nykjaer, C. Woodhead, J. E. Cade, C. P. Gale, and V. J. Burley. 2013. Dietary fibre intake and risk of cardiovascular disease: Systematic review and meta-analysis. BMJ (Clinical Research ed.) 347 (dec19 2):f6879–f6879. doi: 10.1136/bmj.f6879.
  • Tighe, P., G. Duthie, N. Vaughan, J. Brittenden, W. G. Simpson, S. Duthie, W. Mutch, K. Wahle, G. Horgan, and F. Thies. 2010. Effect of increased consumption of whole-grain foods on blood pressure and other cardiovascular risk markers in healthy middle-aged persons: A randomized controlled trial. The American Journal of Clinical Nutrition 92 (4):733–40. doi: 10.3945/ajcn.2010.29417.
  • Tiwari, U., and E. Cummins. 2011. Meta-analysis of the effect of b-glucan intake on blood cholesterol and glucose levels. Nutrition (Burbank, Los Angeles County, Calif.) 27 (10):1008–16. doi: 10.1016/j.nut.2010.11.006.
  • Tosh, S. M., and N. Bordenave. 2020. Emerging science on benefits of whole grain oat and barley and their soluble dietary fibres for heart health, glycemic response, and gut microbiota. Nutrition Reviews 78 (Suppl 1):13–20. doi: 10.1093/nutrit/nuz085.
  • Vogel, R. A., M. C. Corretti, and G. D. Plotnick. 1996. Changes in flow-mediated brachial artery vasoactivity with lowering of desirable cholesterol levels in healthy middle-aged men. The American Journal of Cardiology 77 (1):37–40. doi: 10.1016/s0002-9149(97)89131-x.
  • Wang, Y., N. Ames, S. Li, P. Jones, and E. Khafipour. 2014. High molecular weight barley β-glucan supports bacterial populations beneficial for gut health (647.45). FASEB Journal. 28 (1).
  • Wang, Y., N. P. Ames, H. M. Tun, S. M. Tosh, P. J. Jones, and E. Khafipour. 2016. High molecular weight barley b-glucan alters gut microbiota toward reduced cardiovascular disease risk. Frontiers in Microbiology 7:129. doi: 10.3389/fmicb.2016.00129.
  • Wang, Y., S. Harding, S. Thandapilly, S. Tosh, P. Jones, and N. Ames. 2017. Barley β-glucan reduces blood cholesterol levels via interrupting bile acid metabolism. The British Journal of Nutrition 118 (10):822–9. doi: 10.1017/S0007114517002835.
  • Whelton, S. P., A. D. Hyre, B. Pedersen, Y. Yi, P. K. Whelton, and J. He. 2005. Effect of dietary fiber intake on blood pressure: A meta-analysis of randomized, controlled clinical trials. Journal of Hypertension 23 (3):475–81. doi: 10.1097/01.hjh.0000160199.51158.cf.
  • Whitehead, A., E. J. Beck, S. Tosh, and T. M. S. Wolever. 2014. Cholesterol-lowering effects of oat b-glucan: A meta-analysis of randomized controlled trials. The American Journal of Clinical Nutrition 100 (6):1413–21. doi: 10.3945/ajcn.114.086108.
  • Wolever, T. M., S. M. Tosh, A. L. Gibbs, J. Brand-Miller, A. M. Duncan, V. Hart, B. Lamarche, B. A. Thomson, R. Duss, and P. J. Wood. 2010. Physicochemical properties of oat β-glucan influence its ability to reduce serum LDL cholesterol in humans: A randomized clinical trial. The American Journal of Clinical Nutrition 92 (4):723–32. doi: 10.3945/ajcn.2010.29174.
  • Wouk, J., R. F. H. Dekker, E. A. I. F. Queiroz, and A. M. Barbosa-Dekker. 2021. β-Glucans as a panacea for a healthy heart? Their roles in preventing and treating cardiovascular diseases. International Journal of Biological Macromolecules 177:176–203. doi: 10.1016/j.ijbiomac.2021.02.087.
  • Yang, D., Z. Zhou, and L. Zhang. 2019. An overview of fungal glycan-based therapeutics. Progress in Molecular Biology and Translational Science 163:135–63. doi: 10.1016/bs.pmbts.2019.02.001.
  • Zambell, K. L., M. D. Fitch, and S. E. Fleming. 2003. Acetate and butyrate are the major substrates for de novo lipogenesis in rat colonic epithelial cells. The Journal of Nutrition 133 (11):3509–15. doi: 10.1093/jn/133.11.3509.
  • Zhu, X., X. Sun, M. Wang, C. Zhang, Y. Cao, G. Mo, J. Liang, and S. Zhu. 2015. Quantitative assessment of the effects of beta-glucan consumption on serum lipid profile and glucose level in hypercholesterolemic subjects. Nutrition, Metabolism, and Cardiovascular Diseases: NMCD 25 (8):714–23. Aug doi: 10.1016/j.numecd.2015.04.008.